|
gptkbp:instanceOf
|
gptkb:drug
opioid
|
|
gptkbp:activeIngredient
|
gptkb:meperidine
|
|
gptkbp:approvedBy
|
1940s
|
|
gptkbp:ATCCode
|
N02AB02
|
|
gptkbp:brand
|
gptkb:Pethidine
gptkb:meperidine
Alodan
Centralgin
Dispadol
Dolantin
Dolestine
Dolosal
Mepergan
Meperidine Hydrochloride
Opidol
Pethidine Hydrochloride
Pethilorfan
|
|
gptkbp:chemicalFormula
|
C15H21NO2
|
|
gptkbp:contraindication
|
MAOI use
severe respiratory insufficiency
|
|
gptkbp:controlledSubstanceSchedule
|
gptkb:Schedule_II_(US)
|
|
gptkbp:developedBy
|
gptkb:Sanofi
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
gptkbp:genericName
|
gptkb:meperidine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Demerol
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:riskFactor
|
addiction
overdose
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
subcutaneous
intravenous
|
|
gptkbp:sideEffect
|
nausea
constipation
dizziness
drowsiness
respiratory depression
|
|
gptkbp:usedFor
|
pain management
|
|
gptkbp:bfsParent
|
gptkb:Meperidine
gptkb:meperidine
|
|
gptkbp:bfsLayer
|
7
|